Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam · Delayed Price · Currency is VND 12,500
0.00 (0.00%)
At close: Jul 23, 2026
HOSE:DBT Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Revenue Revenue Growth | 860,313 | 860,313 | 868,411 | 811,616 | 800,500 | 809,914 |
Revenue Growth | -0.93% | -0.93% | 7.00% | 1.39% | -1.16% | 1.23% |
Gross Profit Gross Profit Growth | 338,447 | 338,447 | 346,103 | 309,616 | 185,245 | 181,063 |
Operating Income Operating Income Growth | 45,026 | 45,026 | 49,112 | 67,094 | 29,616 | 27,292 |
Net Income Net Income Growth | 12,849 | 12,849 | 13,200 | 12,964 | 21,396 | 20,193 |
Earnings Per Share EPS Growth | 614.00 | 614.00 | 706.40 | 762.62 | - | - |
EPS Growth | -13.08% | -13.08% | -7.37% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 |
Eliminations Eliminations Growth | -121,494 | -121,494 | -123,644 |
Sale of Merchandise Sale of Merchandise Growth | 902,443 | 902,443 | 890,171 |
Sale of Finished Goods Sale of Finished Goods Growth | 71,468 | 71,468 | 94,336 |
Rendering of Services Rendering of Services Growth | 7,896 | 7,896 | 7,548 |
Total Total Growth | 860,313 | 860,313 | 868,411 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Cash & Investments Cash & Investments Growth | 61,508 | 61,508 | 49,736 | 60,141 | 82,102 | 83,136 |
Total Debt Total Debt Growth | 548,666 | 548,666 | 545,039 | 476,414 | 326,328 | 221,180 |
Net Cash (Debt) Net Cash Growth | -487,157 | -487,157 | -495,303 | -416,273 | -244,226 | -138,044 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -23281.96 | -23281.96 | -26506.61 | -24497.94 | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Operating Cash Flow Operating Cash Flow Growth | -10,851 | -10,851 | -26,796 | 361.64 | -74,118 | -10,814 |
Capital Expenditures CapEx Growth | -2,779 | -2,779 | -14,072 | -7,318 | -6,822 | -10,513 |
Free Cash Flow Free Cash Flow Growth | -13,630 | -13,630 | -40,869 | -6,956 | -80,940 | -21,328 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Gross Margin | 39.34% | 39.34% | 39.86% | 38.15% | 23.14% | 22.36% |
Operating Margin | 5.23% | 5.23% | 5.66% | 8.27% | 3.70% | 3.37% |
Pretax Margin | 2.79% | 2.79% | 2.35% | 2.85% | 3.73% | 3.29% |
Profit Margin | 1.49% | 1.49% | 1.52% | 1.60% | 2.67% | 2.49% |
FCF Margin | -1.58% | -1.58% | -4.71% | -0.86% | -10.11% | -2.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
PE Ratio | 20.52 | 19.23 | 18.98 | 15.36 | 7.53 | 8.07 |
PS Ratio | 0.31 | 0.29 | 0.29 | 0.25 | 0.20 | 0.20 |